Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer
1991

Essential Fatty Acids and Bladder Cancer

Sample size: 98 publication Evidence: moderate

Author Information

Author(s): S. McClinton, L.E.F. Moffat, D.F. Horrobin, M.S. Manku

Primary Institution: Aberdeen Royal Infirmary

Hypothesis

Are the plasma levels of essential fatty acids different in patients with bladder cancer compared to a normal population?

Conclusion

Plasma levels of essential fatty acids are abnormal in patients with bladder cancer, but they do not help distinguish between active and inactive disease.

Supporting Evidence

  • Patients with bladder cancer had significantly lower plasma levels of essential fatty acids compared to a control population.
  • No significant differences were found between patients with active and inactive disease.
  • The study suggests that a deficiency in essential fatty acids may predispose individuals to bladder cancer.

Takeaway

People with bladder cancer have lower levels of certain fats in their blood, but these levels don't help doctors tell if the cancer is getting worse or not.

Methodology

Blood samples were taken from patients with bladder cancer to measure the levels of essential fatty acids in their plasma phospholipids.

Limitations

The study could not determine significant differences between active and inactive disease groups.

Participant Demographics

The study included 98 patients, with 55 having active disease and 43 having inactive disease, primarily middle-aged and elderly individuals.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication